Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.00086 | 1 |
mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.00075 | 1 |
mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.00076 | 1 |
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.00083 | 1 |
mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.00076 | 1 |
mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00078 | 1 |
mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.00072 | 1 |
mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.00062 | 1 |